Cc1cc(Nc2ccc(NS(C)(=O)=O)cc2)c2c(ccc3[nH]ccc32)n1.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?